Biohaven Pharmaceutical Holding Company Ltd

NYSE:BHVN   3:59:56 PM EDT
-2.40 (-1.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.67B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$110.35 Million
Adjusted EPS-$2.47
See more estimates
10-Day MA$133.84
50-Day MA$125.49
200-Day MA$93.72
See more pivots

Biohaven Pharmaceutical Holding Company Ltd Stock, NYSE:BHVN

215 Church Street, New Haven, Connecticut 06510
Virgin Islands, British
Phone: +1.203.404.0410
Number of Employees: 825


Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.